Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT07659587
Enrolling by invitation Not applicable

FIT FIRST for the Bones

NCT07659587 · tracked via the Priya Life Science Denmark tracker
Sponsor
University of Southern Denmark
Phase
Not applicable
Started
2026-01-12
Last updated
2026-06-22

Condition(s) studied

Healthy

Investigational drug(s) / intervention(s)

FIT FIRST

FIT FIRST: Frequent Intense Training (3x40 min pr. week for 18 weeks

Study summary

This study aims to conduct a cluster RCT intervention study with adolescents in Denmark and investigate whether the FIT FIRST concept can improve young people's bone health. We hypothesize that students from the schools randomized to the intervention arm will show greater improvements in bone health than students randomized to the control arm. The experiment will be of societal relevance in relation to evidence for the effects of implementing high-intensity physical activity in school.

Eligibility

Sex
ALL
Min age
13 Years
Max age
16 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Part of participating classes Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Southern Denmark Odense Funen

More University of Southern Denmark trials in Denmark

Influence of Nociception Level Monitor (NOL) Guided Analgesic Delivery on Robot-assisted Colorectal Surgery Recruiting
The ECHO Study: Compassion-focused Therapy for Young Voice Hearers and Their Caregivers Starting soon
Family TIME: A Family-focused Nursing Intervention for Adults Receiving Haemodialysis and Their Families Starting soon
The Bloom Study - a Safe and Healthy Start in Life Recruiting
Attentional Control Training for Treating Alcohol Use Disorder Recruiting

Other trials for the same condition

Urinary Concentration After Salmeterol Recruiting
Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO) Active, not recruiting
Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control Active, not recruiting
GastroFlow: Investigation of the Gastrointestinal Blood Flow in Patients With Postprandial Hypotension Enrolling by invitation
Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07659587 on ClinicalTrials.gov ↗ ← All trials in Denmark